Drug Database
Back to search

Poland· PL-100415821

Acarbose Aurovitas

A acarbose product containing acarbosum, registered in Poland by Aurovitas Pharma Polska Sp. z o.o.. The same ATC class is registered in 13 of our 19 countries.

ATC A10BF01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAcarbose AurovitasATCA10BF01REGISTER NO.PL-100415821PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acarbosumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acarbose is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BF01 (acarbose), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search acarbose products by name

Acarbose · ATC A10BF01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Italyprice
  • Japan
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acarbose costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.52 in Spain to $1.01 in United States — a ×1.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Acarbose · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • US United States$1.01 (acquisition cost)
  • IT Italy$0.96
  • FR France$0.65
  • ES Spain$0.52
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Acarbosum
Manufacturer
Aurovitas Pharma Polska Sp. z o.o.
Country
Poland (PL)
ATC code
A10BF01
ATC class
Acarbose
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991457228
  • gtin
    05909991457235
  • gtin
    05909991457242
  • gtin
    05909991457259

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

461 interactions on record for acarbose.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acarbose against other medicinesHow interaction checks work

Acarbose · interactions on record

461 records

  • 8 severe
  • 262 moderate
  • 46 minor
  • 145 info

Most severe, free to view

  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • GatifloxacinJ01MA16severe
  • PexidartinibL01EX15severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acarbose in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acarbose products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Bulgaria · Ароба
  • Czechia · Acarbose Viatris
  • Germany · Acarbose Al, Acarbose Dura
  • Spain · Acarbosa Farmalider, Acarbosa Qualigen
  • France · Acarbose Arrow, Acarbose Arrow Lab
  • United Kingdom (Northern Ireland) · Acarbose, Acarbose Generics [uk] Ltd
  • Italy · Acarbosio Aurobindo, Acarbosio Doc Generici
  • Portugal · Acarbose Berar Laboratórios Basi - Indústria Farmacêutica, Acarbose Bluepharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7ebe30db-4a39-40b6-8a2c-d957b6455991
GET /v1/drugs/7ebe30db-4a39-40b6-8a2c-d957b6455991?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991457228 ¦ Rp ¦ 140755\n30 tabl.\n05909991457235 ¦ Rp ¦ 140756\n40 tabl.\n05909991457242 ¦ Rp ¦ 140757\n270 tabl.\n05909991457259 ¦ Rp ¦ 140758\n90 tabl.",
  "substance": "Acarbosum 50 mg",
  "common_name": "Acarbosum",
  "pl_product_id": "100415821",
  "pozwolenie_nr": "26482",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about acarbose.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console